132 related articles for article (PubMed ID: 17827752)
21. Antitumor polycyclic acridines. 7. Synthesis and biological properties of DNA affinic tetra- and pentacyclic acridines.
Stanslas J; Hagan DJ; Ellis MJ; Turner C; Carmichael J; Ward W; Hammonds TR; Stevens MF
J Med Chem; 2000 Apr; 43(8):1563-72. PubMed ID: 10780913
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jung MJ; Nam JM; Na Y; Cho WJ; Kwon Y; Lee ES
Bioorg Med Chem; 2010 Mar; 18(6):2245-2254. PubMed ID: 20188578
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of rotenoid derivatives with cytotoxic and topoisomerase II inhibitory activities.
Sangthong S; Krusong K; Ngamrojanavanich N; Vilaivan T; Puthong S; Chandchawan S; Muangsin N
Bioorg Med Chem Lett; 2011 Aug; 21(16):4813-8. PubMed ID: 21741833
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of hydrogen peroxide-induced necrotic cell death with 3-amino-2-indolylmaleimide derivatives.
Dodo K; Katoh M; Shimizu T; Takahashi M; Sodeoka M
Bioorg Med Chem Lett; 2005 Jun; 15(12):3114-8. PubMed ID: 15878276
[TBL] [Abstract][Full Text] [Related]
25. Semi-synthesis, topoisomerase I and kinases inhibitory properties, and antiproliferative activities of new rebeccamycin derivatives.
Moreau P; Gaillard N; Marminon C; Anizon F; Dias N; Baldeyrou B; Bailly C; Pierré A; Hickman J; Pfeiffer B; Renard P; Prudhomme M
Bioorg Med Chem; 2003 Nov; 11(23):4871-9. PubMed ID: 14604648
[TBL] [Abstract][Full Text] [Related]
26. New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.
Luniewski W; Wietrzyk J; Godlewska J; Switalska M; Piskozub M; Peczynska-Czoch W; Kaczmarek L
Bioorg Med Chem Lett; 2012 Oct; 22(19):6103-7. PubMed ID: 22944121
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and cytostatic properties of some 6H-Indolo[2, 3-b][1, 8]naphthyridine derivatives.
Mastalarz H; Jasztold-Howorko R; Rulko F; Croisy A; Carrez D
Arch Pharm (Weinheim); 2004 Aug; 337(8):434-9. PubMed ID: 15293262
[TBL] [Abstract][Full Text] [Related]
28. Advances in indolo[2,3-a]carbazole chemistry: design and synthesis of protein kinase C and topoisomerase I inhibitors.
Pindur U; Kim YS; Mehrabani F
Curr Med Chem; 1999 Jan; 6(1):29-69. PubMed ID: 9873114
[TBL] [Abstract][Full Text] [Related]
29. The synthesis and evaluation of benzannelated-azatoxins: the benzazatoxins.
Miller TA; Vachaspati PR; Labroli MA; Thompson CD; Bulman AL; Macdonald TL
Bioorg Med Chem Lett; 1998 May; 8(9):1065-70. PubMed ID: 9871709
[TBL] [Abstract][Full Text] [Related]
30. Substituted dibenzo[c,h]cinnolines: topoisomerase I-targeting anticancer agents.
Yu Y; Singh SK; Liu A; Li TK; Liu LF; LaVoie EJ
Bioorg Med Chem; 2003 Apr; 11(7):1475-91. PubMed ID: 12628673
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and primary cytotoxicity evaluation of new 5-bromo-3-substituted-hydrazono-1H-2-indolinones.
Karali N; Terzioğlu N; Gürsoy A
Arch Pharm (Weinheim); 2002 Aug; 335(8):374-80. PubMed ID: 12397621
[TBL] [Abstract][Full Text] [Related]
32. Syntheses of novel antitumor dihydroxanthone derivatives with inhibitory activity against DNA topoisomerase II.
Sato S; Suga Y; Yoshimura T; Nakagawa R; Tsuji T; Umemura K; Andoh T
Bioorg Med Chem Lett; 1999 Sep; 9(18):2653-6. PubMed ID: 10509910
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of 3-aryl-4-indolyl-maleimides as potent mutant isocitrate dehydrogenase-1 inhibitors.
Liu X; Hu Y; Gao A; Xu M; Gao L; Xu L; Zhou Y; Gao J; Ye Q; Li J
Bioorg Med Chem; 2019 Feb; 27(4):589-603. PubMed ID: 30600148
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of novel carbazole-rhodanine conjugates as topoisomerase II inhibitors.
Jiang H; Zhang WJ; Li PH; Wang J; Dong CZ; Zhang K; Chen HX; Du ZY
Bioorg Med Chem Lett; 2018 May; 28(8):1320-1323. PubMed ID: 29545100
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives.
Zhou Y; Xu X; Sun Y; Wang H; Sun H; You Q
Bioorg Med Chem Lett; 2013 May; 23(10):2974-8. PubMed ID: 23566520
[TBL] [Abstract][Full Text] [Related]
36. 6-Arylamino-7-chloro-quinazoline-5,8-diones as novel cytotoxic and DNA topoisomerase inhibitory agents.
Park HJ; Kim YS; Kim JS; Lee EJ; Yi YJ; Hwang HJ; Suh ME; Ryu CK; Lee SK
Bioorg Med Chem Lett; 2004 Jul; 14(13):3385-8. PubMed ID: 15177438
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of novel indoline-2,3-dione derivatives as antitumor agents.
Li P; Tan Y; Liu G; Liu Y; Liu J; Yin Y; Zhao G
Drug Discov Ther; 2014 Jun; 8(3):110-6. PubMed ID: 25031042
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of novel indole derivatives as promising DNA-binding agents and evaluation of antitumor and antitopoisomerase I activities.
Lafayette EA; de Almeida SMV; Cavalcanti Santos RV; de Oliveira JF; Amorim CADC; da Silva RMF; Pitta MGDR; Pitta IDR; de Moura RO; de Carvalho Júnior LB; de Melo Rêgo MJB; de Lima MDCA
Eur J Med Chem; 2017 Aug; 136():511-522. PubMed ID: 28531811
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and identification of novel indolo[2,3-a]pyrimido[5,4-c]carbazoles as a new class of anti-cancer agents.
Pierce LT; Cahill MM; Winfield HJ; McCarthy FO
Eur J Med Chem; 2012 Oct; 56():292-300. PubMed ID: 22910137
[TBL] [Abstract][Full Text] [Related]
40. Oligopyrrole carboxamides linked with a nucleobase as potential DNA minor groove binding ligands: synthesis, DNA binding and biological evaluation.
Keuser C; Pindur U
Pharmazie; 2006 Apr; 61(4):261-8. PubMed ID: 16649534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
